Venous Disease Coalition launches new VTE Toolkit for health professionals

The Vascular Disease Foundation's Venous Disease Coalition announced the launch of its new VTE Toolkit, A Practical Overview for Health Professionals. This toolkit was developed by the Venous Disease Coalition (VDC) and may be accessed online at

The VTE Toolkit provides some of the key concepts about venous thromboembolism (VTE) and anticoagulant management. VTE is a common, potentially life-threatening, but treatable and generally preventable disorder that includes two related conditions, deep vein thrombosis (DVT) and pulmonary embolism (PE). This useful resource may be accessed for personal learning as well as educational activities with groups. The content of the toolkit has been carefully selected to reflect the essential current, evidence-based knowledge in the area of VTE.

The Toolkit is a series of 12 PowerPoint slide presentations that may be used separately or as a group. Each chapter can be used in its current form or modified to meet the educational needs of a specific audience or act as a supplement to presenters' existing slides to complement a presentation. The slides are available in PowerPoint (Office 7-PPTX and Office 97-2003-PPT) and PDF formats.

"The VTE Toolkit was designed to be a "living resource", said Dr. Bill Geerts, VDC Steering Committee member and chair of the VDC science committee. "We welcome feedback on the content and encourage users to send us material that can be used to supplement or replace some of the slides and thereby to enhance the quality of this resource."

The VTE Toolkit is a free resource that was created by the VDC and may be found at The toolkit is made possible in part through funding from Eisai, Inc.


Venous Disease Coalition


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Safety-focused summary of GLP-1 receptor agonists in diabetes, obesity, and beyond